Elevated Liver Enzymes With Positive Hepatitis B Serology After Intravenous Immunoglobulin Treatment of Guillain-Barré Syndrome

被引：0
|
作者：
Patel, Shivam [1 ]
Le, Kim Minh Ngoc [2 ]
Puskoor, Sujith [3 ]
Amaning, Judith [2 ]
机构：
[1] Texas A&M Univ, Sch Med, Bryan, TX USA
[2] Baylor Scott & White Med Ctr Round Rock, Dept Gastroenterol, Round Rock, TX 78665 USA
[3] Baylor Scott & White Med Ctr Round Rock, Dept Internal Med, Round Rock, TX USA
来源：
ACG CASE REPORTS JOURNAL | 2023年 / 10卷 / 12期
关键词：
IVIG; Guillain-Barre syndrome; hepatitis B serology; liver enzyme elevation;
D O I：
10.14309/crj.0000000000001207
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Intravenous immunoglobulin (IVIG) is used to treat multiple conditions, one of which is Guillain-Barre syndrome. Despite its multiple benefits, IVIG can cause a wide variety of side effects, most of which resolve with supportive care. We present a case in which a patient with new-onset Guillain-Barre syndrome was treated with IVIG and subsequently developed an acute elevation in liver enzymes with positive hepatitis B serology.
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Acute liver failure due to hepatitis A virus presented with Guillain-Barré syndrome and ocular myasthenia gravis
    Aswanth, K. S.
    Kumar, Vinod
    Akhil, Raj M. S.
    Bhat, Nowneet Kumar
    BMJ CASE REPORTS, 2023, 16 (10)
  • [22] Agranulocytosis following intravenous immunoglobulin administration in a patient with Guillain-Barr? Syndrome triggered by COVID-19: A case report
    Djikic, Marina
    Zdraljevic, Mirjana
    Miladinovic, Tijana
    Milenkovic, Marija
    Berisavac, Ivana
    NEUROLOGY ASIA, 2022, 27 (03) : 783 - 786
  • [23] False-positive hepatitis B serology following intravenous immunoglobulin therapy: forgotten but not gone!!
    Benton, E.
    Iqbal, K.
    Wade, P.
    Wong, T.
    Aarons, E.
    Groves, R. W.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 : 13 - 13
  • [24] Effect of intravenous immunoglobulin and plasmapheresis on nerve conduction parameters compared to the natural course of Guillain-Barr<acute accent>e syndrome
    Kalita, Jayantee
    Mahajan, Roopali
    Kumar, Mritunjai
    JOURNAL OF CLINICAL NEUROSCIENCE, 2024, 125 : 76 - 82
  • [25] Occurrence of Guillain-Barré Syndrome in the Early Post-operative Period After an Urgent Liver Transplant
    Jasqui-Bucay, Ariel
    Moctezuma-Velazquez, Carlos
    Pacheco-Aispuro, Geronimo
    Vilatoba-Chapa, Mario
    Aguirre-Valadez, Jonathan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [26] Clinical study of the relationship between hepatitis B core antibody and mechanical ventilation in patients with Guillain-Barré syndrome
    Zhang, Wei
    Yao, Qian
    Wang, Yuqiao
    Yin, Junxiong
    Yang, Xinxin
    FRONTIERS IN NEUROLOGY, 2025, 16
  • [27] Pompholyx after intravenous immunoglobulin therapy for treatment of Guillain-BarrE syndrome
    Rhee, D-Y
    Park, G-H
    Chang, S-E
    Lee, M-W
    Choi, J-H
    Moon, K-C
    Koh, J-K
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (05) : 602 - 604
  • [28] Good maternal and fetal outcomes of predominantly sensory Guillain–Barré syndrome in pregnancy after intravenous immunoglobulin
    Yasuo Matsuzawa
    Ryuji Sakakibara
    Toshiko Shoda
    Masahiko Kishi
    Emina Ogawa
    Neurological Sciences, 2010, 31 : 201 - 203
  • [29] Case report: Resolution of Guillain-Barré syndrome in a patient with dual primary tumors after treatment with rituximab
    Zhang, Desheng
    Wang, You
    Zhou, Fuxiang
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [30] Reversible Splenial Lesion Syndrome After Intravenous Immunoglobulin Treatment for Guillain-Barre Syndrome
    Kucukseymen, Elif Uygur
    Yuksel, Burcu
    Genc, Fatma
    Goksu, Eylem Ozaydin
    Yildiz, Sevim
    Gomceli, Yasemin Bicer
    CLINICAL NEUROPHARMACOLOGY, 2017, 40 (05) : 224 - 225
12345